LifeMD vs Shedrx: Clinical Considerations & GLP-1 Options

Last reviewed: May 16, 2026

Last updated: May 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

LifeMD and Shedrx represent two distinct telehealth models for GLP-1 medication access, each with different clinical oversight structures and pricing strategies. Both operate through licensed providers, but the depth of initial assessment and ongoing clinical management varies significantly between the two platforms.

Choosing between telehealth GLP-1 providers requires more than price comparison. Understanding medication sourcing, provider qualifications, program flexibility, and whether your own genetic predispositions in peptide pathways might inform treatment decisions helps ensure you receive clinically appropriate care aligned with your health profile.

Program Structure and Provider Oversight Models

LifeMD operates through a network of licensed providers who conduct initial consultations and ongoing monitoring via telehealth. The platform emphasizes direct physician or nurse practitioner evaluation, with medication recommendations based on individual health assessment. Program duration and follow-up frequency vary by patient needs.

Shedrx uses a similar telehealth-first model but structures its program around preset packages with defined visit schedules. This approach offers cost predictability but may limit flexibility for patients who need more frequent adjustments or have complex medical histories requiring deeper clinical oversight.

Medication Sourcing, Formulation, and Availability Comparison

Both platforms offer GLP-1 medications, but sourcing differs. Understanding whether medications are brand-name, generic, or compounded affects cost, consistency, and access. This table outlines key differences in how each platform typically structures medication options.

Program Element	LifeMD Typical Approach	Shedrx Typical Approach	Clinical Consideration
Medication Type	Brand-name and generic options	Brand-name focus with some generics	Brand medications FDA-approved; compounded options may offer cost savings
Sourcing Transparency	Licensed pharmacy network disclosed	Pharmacy partnerships listed	Verify 503A compounding vs. 503B if compounded options discussed
Dose Flexibility	Provider adjusts based on response	Package-based with protocol adjustments	Individualized dosing may require more frequent provider contact
Cost Range (Monthly)	Typically $129-$369/mo depending on medication	Typically $150-$350 with subscription model	Compare total out-of-pocket and whether biomarker testing included

Initial Assessment Depth and Personalization Factors

LifeMD generally conducts comprehensive initial health evaluations including metabolic history, comorbidities, and prior medication responses. This depth helps providers tailor recommendations but requires more time and documentation. Ongoing monitoring typically includes follow-up visits at 6-8 week intervals.

Shedrx streamlines the initial assessment to reduce barriers to access, which benefits patients seeking quick start options but may miss contextual factors affecting medication choice. Genetic predispositions in peptide signaling pathways, for example, could inform whether certain GLP-1 formulations align better with individual physiology, but this level of precision requires deeper initial evaluation.

Safety Considerations and Clinical Eligibility Factors

Both platforms screen for contraindications, including personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, and severe renal or hepatic impairment. Provider oversight quality affects safety monitoring. Patients with complex medical histories benefit from providers who conduct thorough medication interaction checks and adjust dosing based on individual response.

Before choosing between platforms, consider whether you have factors requiring closer clinical supervision: uncontrolled blood pressure, active cardiac disease, or concurrent medications with potential GLP-1 interactions. Patients with genetic variants affecting GLP-1 receptor signaling or glucose metabolism may also benefit from providers experienced in interpreting biomarker context during dose optimization.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context for how your individual genetic variants in key peptide pathways influence GLP-1 receptor signaling and metabolic response. Variants in GLP1R, GIPR, FTO, and MC4R can support a more informed conversation with your healthcare provider about medication selection and expected response patterns.

The genetic test reveals predispositions in peptide pathways—not exact medication response or outcomes. Certain genetic profiles may suggest why some patients experience faster weight reduction or require different dosing strategies, but this information should always be interpreted alongside clinical evaluation, lifestyle factors, and provider guidance.

Whether you select a platform like LifeMD, Shedrx, or explore compounded GLP-1 options through PlexusDx, having your genetic context available during provider consultations can support more personalized clinical decisions and help explain individual variation in medication efficacy and tolerability.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the main difference between LifeMD and Shedrx programs?

LifeMD emphasizes individual provider oversight with flexible dosing, while Shedrx uses preset subscription packages. LifeMD typically conducts deeper initial assessments; Shedrx prioritizes quick access and cost predictability.

How often do I see a provider with each platform?

LifeMD schedules follow-ups based on individual needs, typically 6-8 weeks apart. Shedrx includes preset visit schedules within subscription tiers, usually monthly or quarterly depending on the package selected.

Are LifeMD and Shedrx medications the same as brand-name GLP-1 drugs?

Both platforms offer FDA-approved GLP-1 medications through licensed pharmacies. Brand-name options like Ozempic or Mounjaro may be available, but sourcing and generic alternatives vary by platform and prescription.

Does genetic testing improve outcomes with either platform?

Genetic predispositions in GLP-1 signaling pathways may inform provider conversations about personalization, but genes do not predict exact outcomes. A qualified provider can interpret genetic context alongside clinical assessment to support more informed dosing decisions.

How does PlexusDx compare to LifeMD and Shedrx?

PlexusDx offers compounded GLP-1 medications from licensed 503A pharmacies, paired with genetic testing for peptide pathway predispositions. Compounded options may provide cost savings and flexibility. Consult a provider to determine which model fits your clinical needs and budget.

LifeMD vs Shedrx: Clinical Evaluation for GLP-1 Selection